Previous 10 | Next 10 |
2024-03-05 16:42:18 ET Gainers: Ebang International Holdings ( EBON ) +17% . CrowdStrike Holdings ( CRWD ) +17% . Couchbase ( BASE ) +14% . SOPHiA GENETICS ( SOPH ) +6% . Expensify ( EXFY ) +5% . Losers: ODDITY Tech...
2024-03-05 10:46:04 ET SOPHiA GENETICS SA (SOPH) Q4 2023 Earnings Conference Call March 05, 2024, 08:00 AM ET Company Participants Kellen Sanger - Head, Strategy & Investor Relations Jurgi Camblong - Co-Founder & Chief Executive Officer Ross Muken - Chief...
2024-03-05 06:50:42 ET More on SOPHiA Genetics Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector Seeking Alpha’s Quant Rating on SOPHiA Genetics Historical earnings data for SOPHiA Genetics Financial information for SOPHiA Genetic...
BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Fina...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
BOSTON and ROLLE, Switzerland, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full-year 2023 before U.S. markets open on Tuesda...
2024-02-12 07:58:42 ET Summary Sophia Genetics has a unique market position in the genomics industry, but its business model is at odds with the current direction of the sector. Despite the stock's uptrend in the past year, the company's core assessment remains the same. Sophi...
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain Canada NewsWire SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland...
SOPHiA GENETICS Supports Genetic Testing in Brazil PR Newswire The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities BOSTON and ROLLE, Switzerland , Jan. 25, 2024 /PRNewswire/ -- SOPHiA GEN...
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio PR Newswire RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland , Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (N...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS SA Company Name:
SOPH Stock Symbol:
NASDAQ Market:
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer PR Newswire The hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform BOSTON and ROLLE, Switzerland , May 20, 2024 /PRNewswire/ -- ...
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS PR Newswire The SOPHiA DDM™ Platform will help broaden the hospital's cancer testing and diagnostic capabilities BOSTON and ROLLE, Switzerland , May 16, 2024 /PRNewswire/ -- SO...